Cargando…
Inhibition of farnesyl pyrophosphate synthase improves pressure overload induced chronic cardiac remodeling
Farnesyl pyrophosphate synthase (FPPS) is a key enzyme in the mevalonate pathway. In our previous studies, we find that inhibition of FPPS attenuates angiotensin II-induced cardiac hypertrophy and fibrosis by suppressing RhoA while FPPS and Ras are up-regulated in pressure overload rats. In this stu...
Autores principales: | Zhao, Chen-Ze, Zhao, Xu-Ming, Yang, Jian, Mou, Yun, Chen, Bin, Wu, Huan-Dong, Dai, Dong-Pu, Ding, Jie, Hu, Shen-Jiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5180215/ https://www.ncbi.nlm.nih.gov/pubmed/28008986 http://dx.doi.org/10.1038/srep39186 |
Ejemplares similares
-
Lentiviral-Mediated Silencing of Farnesyl Pyrophosphate Synthase through RNA Interference in Mice
por: Yang, Jian, et al.
Publicado: (2015) -
Computational Insights into Binding of Bisphosphates to Farnesyl Pyrophosphate Synthase
por: Ohno, K, et al.
Publicado: (2011) -
Molecular Cloning and Characterisation of Farnesyl Pyrophosphate Synthase from Tripterygium wilfordii
por: Zhao, Yu-Jun, et al.
Publicado: (2015) -
Positive selection and functional divergence of farnesyl pyrophosphate synthase genes in plants
por: Qian, Jieying, et al.
Publicado: (2017) -
Farnesyl pyrophosphate synthase inhibitor, ibandronate, improves endothelial function in spontaneously hypertensive rats
por: HAN, JIE, et al.
Publicado: (2016)